Abstract:The unmet medical need of patients with multiple sclerosis (MS) is the inexorable loss of CNS myelin and latterly neurons leading to permanent neurologic disability. Solicitation of endogenous oligodendrocytes progenitor cells, the precursor of oligodendrocytes, to remyelinate axons may abort the onset of disability. In female mice with experimental autoimmune encephalomyelitis (EAE), a murine model of MS, adoptive transfer of IL-10+ regulatory B cells (Bregs) has been shown to reverse EAE by promoting the expansion of peripheral and CNS-infiltrating IL-10+ T cells. Here, we examined whether Bregs treatment and its bystander effect on regulatory T cells are associated with CNS repair as reflected by oligodendrogenesis and remyelination. We have found that transfusion of Bregs reverses established clinical EAE and that clinical improvement is associated with a significant increase in spinal cord remyelination as reflected by g-ratio analysis within the thoracic and lumbar spine. We further observed in the spinal cords of EAE Bregs-treated mice that CNS resident CD11b/CD45intLy6C– microglia, and infiltrating CD11b+/CD45high monocytes/macrophages content reverts to normal and polarize to a M2-like CD206+ phenotype. Concurrently, there was a substantial increase in neo-oligodendrogenesis as manifest by an increase in CD45–/low CNS cells expressing A2B5, an early marker in oligodendrocytes progenitor cell differentiation as well as GalC+/O1+ premyelinating and myelin basic protein+/myelin oligodendrocyte glycoprotein+ mature oligodendrocytes with reciprocal downregulation of paired related homeobox protein 1. These results demonstrate that the clinical benefit of Bregs is associated with normalization of CNS immune milieu and concurrent activation of oligodendrocyte progenitor cells with subsequent remyelination. SIGNIFICANCE STATEMENT In multiple sclerosis patients, demyelination progresses with aging and disease course, leading to irreversible disability. In this study, we have discovered, using a mouse model of multiple sclerosis, that the transfusion of autologous regulatory B cells (Bregs) is able to ameliorate, cure, and sustain the durable remission of the disease. We show that the adoptive transfer of Bregs dramatically decreased the frequency of myeloid-derived cells, both infiltrating monocytes/macrophages and resident microglia, and converted their phenotype to an immunosuppressive-like phenotype. Moreover, we showed that CNS oligodendrocyte progenitor cells are activated following Bregs treatment and differentiate into myelinating oligodendrocytes, which results in neo-oligodendrogenesis and remyelination of spinal cords.

Regulatory T cells promote myelin regeneration in the central nervous system

Ageing impairs the regenerative capacity of regulatory T cells in mouse central nervous system remyelination

M2 Microglia and Macrophages Drive Oligodendrocyte Differentiation During CNS Remyelination

Microglia regulate central nervous system myelin growth and integrity

Remyelination in the CNS: from biology to therapy

Astrocyte-Oligodendrocyte interaction regulates central nervous system regeneration

Regenerative Capacity of Macrophages for Remyelination

Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis

[Neuroscience] Remyelination in the Central Nervous System

Remyelination reporter reveals prolonged refinement of spontaneously regenerated myelin

Rejuvenation of Regeneration in the Aging Central Nervous System.

Microglia regulate cortical remyelination via TNFR1-dependent phenotypic polarization

Clinical implications of myelin regeneration in the central nervous system

Oligodendrocyte progenitor programming and reprogramming: Toward myelin regeneration

Preventing production of new oligodendrocytes impairs remyelination and sustains behavioural deficits after demyelination

Microglial transglutaminase-2 drives myelination and myelin repair via GPR56/ADGRG1 in oligodendrocyte precursor cells

Myelin-based inhibitors of oligodendrocyte myelination: clues from axonal growth and regeneration

Regulatory B Cells Normalize CNS Myeloid Cell Content in a Mouse Model of Multiple Sclerosis and Promote Oligodendrogenesis and Remyelination

Central nervous system regeneration: the roles of glial cells in the potential molecular mechanism underlying remyelination

Strategies for myelin regeneration: lessons learned from development

Microglia-derived exosomes modulate myelin regeneration via miR-615-5p/MYRF axis